Arcadia Biosciences Inc.

5.09
-0.06 (-1.17%)
At close: Jan 28, 2025, 1:21 PM

Arcadia Biosciences Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018
Product Revenue 1.54M 1.31M 1.25M 1.38M 1.51M 993.00K 1.85M 2.95M 3.17M 2.08M 2.32M 1.38M 803.00K 414.00K 245.00K 231.00K 154.00K 329.00K 216.00K 162.00K 107.00K 144.00K 188.00K
Product Revenue Growth +17.69% +4.06% -8.99% -8.61% +51.96% -46.35% -37.17% -7.07% +52.33% -10.46% +68.53% +71.73% +93.96% +68.98% +6.06% +50.00% -53.19% +52.31% +33.33% +51.40% -25.69% -23.40% n/a

Revenue by Geography

Quarter Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Argentina Revenue 862.00K 26.00K 6.68M 258.00K 91.00K 1.06M 202.00K
Argentina Revenue Growth +3215.38% -99.61% +2489.53% +183.52% -91.45% +426.73% n/a
Canada Revenue 194.00K 503.00K 354.00K 7.00K 90.00K 181.00K 2.71M
Canada Revenue Growth -61.43% +42.09% +4957.14% -92.22% -50.28% -93.33% n/a
Germany Revenue 57.00K 7.00K 100.00K 722.00K 1.17M 1.59M n/a
Germany Revenue Growth +714.29% -93.00% -86.15% -38.18% -26.45% n/a n/a
India Revenue 7.00K 6.00M 761.00K n/a n/a n/a n/a
India Revenue Growth -99.88% +688.83% n/a n/a n/a n/a n/a
United States Revenue 8.84M n/a n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 2.24M 2.68M 3.19M 3.42M 3.44M 3.81M 4.39M 4.21M 4.83M 4.65M 4.35M 6.19M 6.31M 6.37M 4.07M 4.78M 4.29M 3.67M 3.72M 3.13M 4.48M 3.15M 2.81M 3.02M 3.01M 2.95M 2.62M 2.24M 2.42M 2.94M 3.05M 3.37M 2.69M 2.76M 3.44M 2.88M 2.82M 2.79M 2.64M
Selling, General, and Administrative Revenue Growth -16.47% -15.87% -6.84% -0.58% -9.75% -13.14% +4.22% -12.84% +3.93% +6.97% -29.72% -1.96% -0.91% +56.55% -14.84% +11.32% +16.82% -1.32% +18.83% -30.02% +42.35% +11.84% -6.98% +0.40% +2.10% +12.51% +16.96% -7.20% -17.94% -3.57% -9.38% +25.34% -2.61% -19.70% +19.39% +2.13% +1.18% +5.57% n/a
Research and Development Revenue 24.00K 10.00K 272.00K 332.00K 305.00K 391.00K 359.00K 500.00K 255.00K 359.00K 395.00K 561.00K 1.04M 1.13M 1.16M 1.96M 1.76M 1.99M 2.24M 1.71M 1.93M 1.95M 1.50M 1.54M 1.33M 1.79M 1.40M 2.17M 1.75M 1.67M 1.82M 1.99M 2.25M 2.22M 2.20M 1.87M 3.18M 2.09M 1.83M
Research and Development Revenue Growth +140.00% -96.32% -18.07% +8.85% -21.99% +8.91% -28.20% +96.08% -28.97% -9.11% -29.59% -45.95% -8.22% -2.42% -40.90% +11.29% -11.59% -11.19% +31.15% -11.39% -0.97% +29.57% -2.59% +15.82% -25.64% +28.51% -35.55% +23.84% +4.79% -8.45% -8.39% -11.75% +1.76% +0.64% +17.82% -41.21% +52.40% +13.86% n/a